Email
Print
Tomosynthesis Market - By Type (2D Tomosynthesis, 3D Tomosynthesis), By Application (Breast Cancer Screening, Chest Imaging, Evaluation of Erosions in Rheumatoid Arthritis, Head and Neck Imaging, etc.), By Segmentation (Regulatory Framework, Technological Insights, etc), By Market Analysis (Introduction, Segment Overview, Hospitals, Diagnostic Centers, etc.), By Geography - Global Opportunity Analysis & Industry Forecast, 2022-2030
Tomosynthesis Market Overview:
The Tomosynthesis market can be segmented based on end-users and regions. It is projected to achieve a significant market size of $3500 billion by 2030, with a compound annual growth rate (CAGR) of 14% during the forecast period of 2023-2030.
The adoption of this market, also known as 3D mammography, is on the rise in the medical imaging field. It offers numerous benefits compared to traditional 2D mammography, including enhanced cancer detection rates and improved visualization of breast abnormalities. The growth is primarily fueled by factors such as the increasing incidence of breast cancer, technological advancements, and the demand for more precise diagnostic tools.
Regulatory approvals in multiple countries have facilitated the integration of Tomosynthesis into healthcare facilities and imaging centers. However, there are some challenges associated with this technology, such as high equipment costs, limited availability in certain regions, and the necessity for specialized training for radiologists.
For the most up-to-date and comprehensive market information, it is recommended to consult industry reports, market research studies, and the latest news developments in this field.
Market Snapshot:
Tomosynthesis Market- Report Coverage:
The “Tomosynthesis Market Report - Forecast (2023-2030)” by IndustryARC, covers an in-depth analysis of the following segments in the Biochar Market.
Tomosynthesis Market - Top Trends:
Increasing Adoption: The use of 3D mammography, also known as Tomosynthesis, has been on the rise, with healthcare providers worldwide increasingly incorporating this advanced technology. It offers improved accuracy in cancer detection compared to traditional 2D mammography, leading to earlier diagnosis and better patient outcomes.
Growing Focus on Breast Cancer Screening: Cancer remains a significant global health concern, and early detection is crucial for successful treatment. Tomosynthesis has emerged as an important tool for cancer screening due to its ability to provide detailed 3D images of tissue, reducing false-positive and false-negative results.
Technological Advancements: The market has witnessed continuous technological advancements to enhance image quality, reduce radiation exposure, and improve the overall patient experience.
Integration with Other Imaging Modalities: Integration of with other imaging modalities, such as ultrasound and magnetic resonance imaging (MRI), is gaining traction. This integration enables a more comprehensive evaluation of breast abnormalities and assists in guiding biopsy procedures.
Tomosynthesis Market - Company Analysis
The market is a rapidly growing sector within the medical industry, also known as 3D mammography, is an advanced technique that allows for the creation of three-dimensional images of the breast using X-ray technology. It offers improved accuracy in detecting breast cancer compared to traditional mammography, especially in dense breast tissue.
When analyzing the companies in the market, several key players stand out. Here are some prominent companies involved in the development and manufacturing of the system
Hologic, Inc.: is a leading company, known for its innovative 3D mammography systems. Their flagship product, the Hologic Selenia Dimensions system, is widely used in breast cancer screening and diagnosis.
GE Healthcare: GE Healthcare is a major player in the medical field, including. Their Sinclair system combines digital mammography with enhanced capabilities for breast cancer detection.
Siemens Healthineers: this company offers Tomosynthesis solutions as part of its comprehensive mammography portfolio. Their systems, such as the MAMMOMAT Revelation, provide advanced options for breast cancer screening.
Fujifilm Holdings Corporation: Fujifilm has a strong presence in with its Amulet Inn ovality system. The company's offering focuses on improving the accuracy of breast cancer diagnosis through advanced imaging technologies.
Planmed Oy: this company specializes in breast imaging equipment, including Tomosynthesis systems. Their Planned Clarity 3D system is designed to provide high-quality images for efficient breast cancer screening.
Key Market Players:
Product/Service launches, approvals, patents and events, acquisitions, partnerships and collaborations are key strategies players in the Tomosynthesis Market adopt. The top 10 companies in Tomosynthesis Market are listed below:
- Hologic, Inc
- GE Healthcare
- Siemens Healthineers
- Fujifilm Holdings Corporation
- Planmed Oy
- Dexela ltd
- PerkinElmer
- Trivitron Healthacre
- iCAD
- Toshiba Medical Systems
Scope of Report:
For more Lifesciences and Healthcare Market reports, please Click Here
1. Tomosynthesis Market Overview
1.1 Definitions and Scope
2. Tomosynthesis Market– Executive Summary
3. Tomosynthesis Market– Market Landscape
3.1 Company Benchmarking – Key Companies
3.2 Key Company Financial Analysis
3.3 Market Share Analysis – Key Companies
3.4 Patent Analysis
3.5 Pricing Analysis (Comparison of General Price Offerings in the Market)
4. Tomosynthesis Market– Startup Company Scenario
4.1 Investment
4.2 Revenue
4.3 Venture Capital and Funding Scenario
5. Tomosynthesis Market– Market Entry Scenario Premium
5.1 Regulatory Scenario
5.2 New Business and Ease of Doing business index
5.3 Case Studies of Successful Ventures
6. Tomosynthesis Market– Market Forces
6.1 Market Drivers
6.2 Market Constraints
6.3 Porter’s Five Force Model
6.3.1 Bargaining Power of Suppliers
6.3.2 Bargaining Powers of Customers
6.3.3 Threat of New Entrants
6.3.4 Rivalry Among Existing Players
6.3.5 Threat of Substitutes
7. Tomosynthesis Market– Strategic Analysis
7.1 Value Chain Analysis
7.2 Opportunities Analysis
7.3 Market Life Cycle Analysis
8. Tomosynthesis Market– By Type (Market Size - $Million/$Billion)
8.1 2D Tomosynthesis
8.1.1 Market Trends by Region
8.1.2 Market Share & Forecast by Region
8.2 3D Tomosynthesis
8.2.1 Market Trends by Region
8.2.2 Market Share & Forecast by Region
8.3 Others
9. Tomosynthesis Market – By Application (Market Size - $Million/$Billion)
9.1 Breast Cancer Screening
9.1.1 Market Trends by Region
9.1.2 Market Share & Forecast by Region
9.2 Chest Imaging
9.2.1 Market Trends by Region
9.2.2 Market Share & Forecast by Region
9.3 Evaluation of Erosions in Rheumatoid Arthritis
9.3.1 Market Trends by Region
9.3.2 Market Share & Forecast by Region
9.4 Head and Neck Imaging
9.4.1 Market Trends by Region
9.4.2 Market Share & Forecast by Region
9.5 Others
9.5.1 Market Trends by Region
9.5.2 Market Share & Forecast by Region
10. Tomosynthesis Market Segmentation & Impact Analysis
10.1 Regulatory Framework
10.1.1 Market Trends by Region
10.1.2 Market Share & Forecast by Region
10.2 Technological Insights
10.2.1 Market Trends by Region
10.2.2 Market Share & Forecast by Region
11. Tomosynthesis Market– By Market Analysis (Market Size - $Million/$Billion)
11.1 Introduction
11.2 Segment Overview
11.2.1 Market Trends by Region
11.2.2 Market Share & Forecast by Region
11.3 Hospitals
11.3.1 Market Trends by Region
11.3.2 Market Share & Forecast by Region
11.4 Diagnostic Centers
11.4.1 Market Trends by Region
11.4.2 Market Share & Forecast by Region
12. Tomosynthesis Market– by Geography (Market Size - $Million/$Billion)
12.1 North America
12.1.1 U.S.
12.1.2 Canada
12.1.3 Mexico
12.2 Europe
12.2.1 Germany
12.2.2 France
12.2.3 U.K.
12.2.4 Italy
12.2.5 Spain
12.2.6 Russia
12.2.7 Rest of Europe
12.3 Asia-Pacific
12.3.1 China
12.3.2 Japan
12.3.3 South Korea
12.3.4 India
12.3.5 Australia & New Zealand
12.3.6 Rest of Asia-Pacific
12.4 South America
12.4.1 Brazil
12.4.2 Argentina
12.4.3 Chile
12.4.4 Colombia
12.4.5 Rest of South America
12.5 Rest of the World
12.5.1 Middle East
12.5.2 Africa
13. Tomosynthesis Market– Market Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships
14. Tomosynthesis Market– Industry Competition Landscape
14.1 Market Share Analysis
14.1.1 Market Share by Technology – Key Companies
14.1.2 Market Share by Country – Key Companies
14.1.3 Market Share by Region – Key Companies
14.2 Competition Matrix
14.3 Best Practices for Companies
15. Tomosynthesis Market– Key Company List by Country Premium
16. Tomosynthesis Market– Company Analysis
16.1 Hologic Inc
16.2 GE Healthcare
16.3 Siemens Healthineers
16.4 Fujifilm Holdings Corporation
16.5 Planmed Oy
16.6 Dexela ltd
16.7 PerkinElmer
16.8 Trivitron Healthacre
16.9 iCAD
16.10 Toshiba Medical Systems
16.11 General Electric Company
16.12 Inc
16.13 Koninklijke Philips N.V
16.14 Fujifilm Medical Systems U.S.A Inc
16.15 Agfa-Gevaert Group
16.16 Analogic Corporation
16.17 Shimadzu
16.18 Planmeca
"Financials would be provided to private companies on best-efforts basis."
Connect with our experts to get customized reports that best suit your requirements. Our reports include global-level data, niche markets and competitive landscape.
The Tomosynthesis Market is projected to grow at 14% CAGR during the forecast period 2023-2030.
Tomosynthesis Market size is estimated to reach 3500 billion by 2030
The Top Companies in the Tomosynthesis Market are Hologic, Inc, GE Healthcare, Siemens Healthineers, Fujifilm Holdings Corporation, Planmed, Dexela ltd, PerkinElmer, Trivitron Healthacre, iCAD, Toshiba Medical Systems